Literature DB >> 7951696

Postmortem changes in the levels and localization of microtubule-associated proteins (tau, MAP2 and MAP1B) in the rat and human hippocampus.

C Schwab1, V Bondada, D L Sparks, L D Cahan, J W Geddes.   

Abstract

The neuronal cytoskeleton is disrupted in neurodegenerative disorders such as Alzheimer's disease. Due to the lack of suitable animal models, studies examining the events involved in the neurodegeneration have relied on postmortem human brain tissue obtained from individuals with the disease and from normal controls. However, it is uncertain if the neuronal cytoskeleton is stable during the postmortem interval. Immunohistochemistry and immunoblots were used to examine the microtubule-associated proteins tau, MAP2, and MAP1B in the rat hippocampus at various times after death. Shortly after death, tau immunoreactivity was lost from axons and accumulated in somatodendritic compartments. MAP2 and MAP1B also accumulated in neuronal cell bodies prior to a loss of immunostaining in some regions, notably subiculum. Immunoblots confirmed a loss of MAP2 and MAP1B within a few hours after death. Tau levels remained constant during the 8-hour postmortem interval examined, although the electrophoretic mobility of some tau bands was altered. Human brain tissue obtained at autopsy and at surgery demonstrated similar cytoskeletal alterations in postmortem tissue. These results demonstrate that microtubules and associated proteins are not stable postmortem.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7951696     DOI: 10.1002/hipo.450040212

Source DB:  PubMed          Journal:  Hippocampus        ISSN: 1050-9631            Impact factor:   3.899


  9 in total

1.  Impact of temperature dependent sampling procedures in proteomics and peptidomics--a characterization of the liver and pancreas post mortem degradome.

Authors:  Birger Scholz; Karl Sköld; Kim Kultima; Celine Fernandez; Sofia Waldemarson; Mikhail M Savitski; Marcus Söderquist; Mats Borén; Robert Stella; Per Andrén; Roman Zubarev; Peter James
Journal:  Mol Cell Proteomics       Date:  2010-01-28       Impact factor: 5.911

Review 2.  Current status of fluid biomarkers in mild traumatic brain injury.

Authors:  Jacqueline R Kulbe; James W Geddes
Journal:  Exp Neurol       Date:  2015-05-14       Impact factor: 5.330

3.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

4.  Temporal profiles of cytoskeletal protein loss following traumatic axonal injury in mice.

Authors:  Gulyeter Serbest; Matthew F Burkhardt; Robert Siman; Ramesh Raghupathi; Kathryn E Saatman
Journal:  Neurochem Res       Date:  2007-03-31       Impact factor: 3.996

5.  Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction.

Authors:  J N Keller; M S Kindy; F W Holtsberg; D K St Clair; H C Yen; A Germeyer; S M Steiner; A J Bruce-Keller; J B Hutchins; M P Mattson
Journal:  J Neurosci       Date:  1998-01-15       Impact factor: 6.167

Review 6.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

7.  Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.

Authors:  Miranda L Bader Lange; Giovanna Cenini; Marta Piroddi; Hafiz Mohmmad Abdul; Rukhsana Sultana; Francesco Galli; Maurizio Memo; D Allan Butterfield
Journal:  Neurobiol Dis       Date:  2007-11-12       Impact factor: 5.996

8.  Proteomics-derived cerebrospinal fluid markers of autopsy-confirmed Alzheimer's disease.

Authors:  Alex E Roher; Chera L Maarouf; Lucia I Sue; Yiran Hu; Jeffrey Wilson; Thomas G Beach
Journal:  Biomarkers       Date:  2009-11       Impact factor: 2.658

9.  Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.

Authors:  Chera L Maarouf; Tracy M Andacht; Tyler A Kokjohn; Eduardo M Castaño; Lucia I Sue; Thomas G Beach; Alex E Roher
Journal:  Curr Alzheimer Res       Date:  2009-08       Impact factor: 3.498

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.